Medium impact
Pharmacy coverage changes
Harvard Pilgrim Health Care·Effective Nov 1, 2025
HCPCS J3250 is officially defined as "Injection, trimethobenzamide hcl, up to 200 mg." HCPCS J3250 is referenced in 1 tracked payer policy change from Harvard Pilgrim Health Care. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J3250 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.